在世卫组织2级质瘤中,无进展的生存率与进展后的生存率和整体生存率对比
Lisa Millgård Sagberg1, Øyvind Salvesen2, Asgeir Store Jakola3
1Department of Neurosurgery, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway; Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway. lisa.millgard.sagberg@ntnu.no.
Acta oncologica (Stockholm, Sweden)
|October 21, 2024
概括
无进展存活率 (PFS) 与世卫组织扩散的2级质瘤的整体存活率 (OS) 有较弱的相关性. 预测PFS不一定预测OS,强调需要PFS验证作为结果测量.
科学领域:
- 神经瘤学神经瘤学
- 临床试验方法论 临床试验方法论
- 癌症研究 癌症研究
背景情况:
- 分散的世卫组织2级质瘤需要经过验证的结果测量.
- 对于这些瘤的无进展生存率 (PFS),后进展生存率 (PPS) 和整体生存率 (OS) 之间的关系,知识有限.
研究的目的:
- 评估PFS和OS之间的相关性在分散的 supratentorialWHO2级质瘤中.
- 在这个患者群体中确定与PFS,PPS和OS相关的因素.
主要方法:
- 分析了来自三个独立观察队列的319名患者.
- 利用PFS和从进展到死亡的时间的独立指数分布.
- 采用Cox的比例危险模型来确定对PFS,PPS和OS的共变效应.
主要成果:
- 在PFS和OS之间发现了一个弱的整体相关性 (rs=0.31).
- 星形细胞瘤显示的相关性更强 (rs=0.37),而不是寡质细胞瘤 (rs=0.19).
- 预测PFS的预测因素,如较大的瘤体积和早期的联合治疗,并不一定是OS或PPS的预测因素.
结论:
- 在世卫组织2级质瘤中,PFS和OS之间存在微弱的相关性,特别是质瘤.
- 在PFS和PPS之间没有发现任何关联.
- 这些发现强调了需要验证PFS作为分散的世卫组织2级质瘤的可靠终点.
相关概念视频
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Comparing the Survival Analysis of Two or More Groups
155
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
155
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328


